Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies
Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and ...
ProLynx Announces Publication of Its Once Monthly Semaglutide in the Proceedings of the National Academy of Sciences
ProLynx Inc., a biotechnology company developing proprietary systems to extend the half-life, improve efficacy, and reduce ...
itc.ua1h
Half-Life 2 has received full Ukrainian localization. How to install?
YouTuber Denys Shvetsov (Rendaros UA) reported announced on its Twitter account that HamUA studio has released a full-fledged Ukrainian localization o ...
Apogee Therapeutics Highlights Progress And Best-In-Class Potential Of Novel Biologic Programs For I&I Diseases At 2024 Inaugural R&D Day
Positive interim Phase 1 data indicate APG808 was well-tolerated with half-life of approximately 55 days, supporting potential for 2- to 3- month dos ...
Games Inbox: Has the Nintendo Switch 2 been delayed?
The Monday letters page thinks Forza Horizon 5 on PS5 would be the final straw for fans, as one reader looks forward to more ...
Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024
Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate clinically meaningful activity in 2L+ HNSCC– Conference call on ...
Team Fortress 2 favorite confirms they’re back in Deadlock
The voice behind Team Fortress 2's Sniper, John Lowrie, confirms that they indeed play a character in Valve's new MOBA ...